Characterising the phenotypic evolution of circulating tumour cells during treatment
Monitoring the heterogeneity of circulating tumour cells (CTCs) and their phenotypic changes during treatment is a challenge. This study describes and tests a method for detection and quantitative heterogeneity analysis of melanoma CTCs in 10 stage-IV melanoma patients.
Guardado en:
Autores principales: | Simon Chang-Hao Tsao, Jing Wang, Yuling Wang, Andreas Behren, Jonathan Cebon, Matt Trau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25b0a256e8aa44ca98dcaa0e998c2cd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
por: Laura Escudero, et al.
Publicado: (2020) -
A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy
por: Junrong Li, et al.
Publicado: (2021) -
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia
por: Paul Yeh, et al.
Publicado: (2017) -
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours
por: Christopher D. Bennett, et al.
Publicado: (2018) -
Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer
por: Shuyun Pang, et al.
Publicado: (2021)